Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing
Thursday, January 20, 2022Seegene Inc South Koreas leading molecular diagnostics company announced today the upcoming launch of the Allplex SARSCoV Fast PCR Assay which can deliver PCR results in just minutes The company says that this assay is expected to reduce the total t...
Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
Wednesday, January 19, 2022Boehringer Ingelheim a global leader in animal health and MabGenesis a private biopharmaceutical company headquartered in Yokohama Japan announce that they have entered into a collaboration to discover and develop novel monoclonal antibodies for pote...
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Wednesday, January 19, 2022Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficulttotreat genomically defined cancers today announced that the US Food and Drug Administration FDA has cleared t...
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's Global Phase II Clinical Trial in Treating Parkinson's Disease
Monday, January 17, 2022Green Valley Shanghai Pharmaceuticals Co Ltd received the letter from the US Food and Drug Administration FDA on the Investigational New Drug IND application for the global multicenter phaseII clinical trial of Oligomannate marketed as GV the company...
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
Wednesday, January 12, 2022BigHat Biosciences Inc a biotechnology company with an artificial intelligencemachine learningguided antibody discovery and development platform today announced the successful completion of the first stage of a previously undisclosed research collabo...
Neutron Therapeutics and Cosylab Announce Strategic Collaboration to Bring Boron Neutron Capture Therapy to Patients
Wednesday, January 12, 2022Neutron Therapeutics a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy BNCT and Cosylab the worlds leading provider of control systems for the planets most complex machines today announced the...
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
Tuesday, January 11, 2022Century Therapeutics and Bristol Myers Squibb announced a research collaboration and license agreement the agreement to develop and commercialize up to four induced pluripotent stem cell iPSC derived engineered natural killer cell iNK and or T cell...
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Tuesday, January 11, 2022Pfizer Inc and Acuitas Therapeutics a company focused on developing lipid nanoparticle LNP delivery systems to enable messenger RNA mRNAbased therapeutics today announced they have entered into a Development and Option agreement under which Pfizer wi...
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Monday, January 10, 2022Bayer AG and Mammoth Biosciences Inc which is harnessing the diversity of nature to power the nextgeneration CRISPR products today announced a strategic collaboration and option agreement for the use of Mammoths CRISPR systems to develop in vivo gene...
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
Monday, January 10, 2022Novartis and Molecular Partners today announced that Part A of the EMPATHY clinical trial that compared single intravenous doses of ensovibep a DARPin antiviral therapeutic candidate vs placebo to treat COVID met the primary endpoint of viral load re...
